Putative COVID-19 therapies imatinib, lopinavir, ritonavir, and ivermectin cause hair cell damage: A targeted screen in the zebrafish lateral line
The biomedical community is rapidly developing COVID-19 drugs to bring much-need therapies to market, with over 900 drugs and drug combinations currently in clinical trials. While this pace of drug development is necessary, the risk of producing therapies with significant side-effects is also increa...
Main Authors: | Allison B. Coffin, Emily Dale, Emilee Doppenberg, Forrest Fearington, Tamasen Hayward, Jordan Hill, Olivia Molano |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fncel.2022.941031/full |
Similar Items
-
PI3K and Inhibitor of Apoptosis Proteins Modulate Gentamicin- Induced Hair Cell Death in the Zebrafish Lateral Line
by: Heather Wiedenhoft, et al.
Published: (2017-10-01) -
Berbamine Analogs Exhibit Differential Protective Effects From Aminoglycoside-Induced Hair Cell Death
by: Alexandria M. Hudson, et al.
Published: (2020-07-01) -
Macrophage Recruitment and Epithelial Repair Following Hair Cell Injury in the Mouse Utricle
by: Tejbeer eKaur, et al.
Published: (2015-04-01) -
Macrophages Respond Rapidly to Ototoxic Injury of Lateral Line Hair Cells but Are Not Required for Hair Cell Regeneration
by: Mark E. Warchol, et al.
Published: (2021-01-01) -
Impact of Nicotine Exposure on Hair Cell Toxicity and Embryotoxicity During Zebrafish Development
by: Myung Hoon Yoo, et al.
Published: (2018-06-01)